StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Cash

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Jun 23, 2022 7:07pm

142 Views

Post# 34778858

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Cash

As you have known from day one that stagezero would fall o wise one then you should be able to tell us how they are still operating today without a pp. they should be out of money as brad has said.

do I think that a miracle will happen? Nope I still believe after the vote we will then see just how bad the company and current investors are $crewed

but what trickery are they using to remove operational yet not getting money from any new source.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market